To rule out thrombophilia, we planned to perform thrombophilia-related examinations, including factor V Leiden, prothrombin 20210A mutation, protein C, protein S, and antiphospholipid antibody, but the patient declined the investigations due to financial constraints. The gene discussed is F2; the disease is thrombophilia.